(San Francisco-AP) -- Bayer
is defending itself against the claims of thousands of hemophiliacs,
who say Bayer knowingly sold them blood-clotting products
that were tainted with H-I-V and hepatitis C.
Sick hemophiliacs in countries outside the U-S sued Bayer
and other companies yesterday.
They claim the companies made products from the blood of
sick, high-risk donors, and distributed them abroad in 1984
and 1985. That was shortly after the companies stopped selling
them in the United States because of the known risk of H-I-V
and hepatitis transmission.
The medicine -- called Factor Eight concentrate -- can stop
or prevent potentially fatal bleeding in people with hemophilia.
Today Bayer rejected the accusations, saying it complied
with all regulations in the countries where it sent its products.
Link
to Article
|
